These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 24733801)

  • 21. Dabrafenib: first global approval.
    Ballantyne AD; Garnock-Jones KP
    Drugs; 2013 Aug; 73(12):1367-76. PubMed ID: 23881668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overcoming metastatic melanoma with BRAF inhibitors.
    Hong S; Hong S; Han SB
    Arch Pharm Res; 2011 May; 34(5):699-701. PubMed ID: 21656352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dabrafenib plus trametinib in BRAF K601E-mutant melanoma.
    Rogiers A; Thomas D; Vander Borght S; van den Oord JJ; Bechter O; Dewaele M; Rambow F; Marine JC; Wolter P
    Br J Dermatol; 2019 Feb; 180(2):421-422. PubMed ID: 30248172
    [No Abstract]   [Full Text] [Related]  

  • 24. Resistance surveillance in a BRAF mutant melanoma patient on long-term BRAF-inhibitor treatment.
    Mak G; Arkenau HT; Chin M
    Melanoma Res; 2014 Aug; 24(4):408-12. PubMed ID: 24858661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NICE guidance on dabrafenib for treating unresectable or metastatic BRAF V600 mutation-positive melanoma.
    Tucker H; Umeweni N; Robertson J; Adam J
    Lancet Oncol; 2014 Dec; 15(13):1425-1426. PubMed ID: 25499274
    [No Abstract]   [Full Text] [Related]  

  • 26. New RAF kinase inhibitors in cancer therapy.
    Martin-Liberal J; Larkin J
    Expert Opin Pharmacother; 2014 Jun; 15(9):1235-45. PubMed ID: 24766074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BRAF mutation-positive folliculotropic metastatic melanoma.
    Brick KE; Halling KC; Khan YK; Peters MS
    Am J Dermatopathol; 2013 Jul; 35(5):609-12. PubMed ID: 23715079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II trial (BREAK-2) of the BRAF inhibitor dabrafenib (GSK2118436) in patients with metastatic melanoma.
    Ascierto PA; Minor D; Ribas A; Lebbe C; O'Hagan A; Arya N; Guckert M; Schadendorf D; Kefford RF; Grob JJ; Hamid O; Amaravadi R; Simeone E; Wilhelm T; Kim KB; Long GV; Martin AM; Mazumdar J; Goodman VL; Trefzer U
    J Clin Oncol; 2013 Sep; 31(26):3205-11. PubMed ID: 23918947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BRAF inhibitor activity in V600R metastatic melanoma--response.
    Klein O; Clements A; Menzies AM; O'Toole S; Kefford RF; Long GV
    Eur J Cancer; 2013 May; 49(7):1797-8. PubMed ID: 23490649
    [No Abstract]   [Full Text] [Related]  

  • 30. Dabrafenib in the treatment of advanced melanoma.
    Medina T; Amaria MN; Jimeno A
    Drugs Today (Barc); 2013 Jun; 49(6):377-85. PubMed ID: 23807941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian cohort of the ipilimumab expanded access program.
    Ascierto PA; Simeone E; Sileni VC; Del Vecchio M; Marchetti P; Cappellini GC; Ridolfi R; de Rosa F; Cognetti F; Ferraresi V; Testori A; Queirolo P; Bernengo MG; Guida M; Galli L; Mandalà M; Cimminiello C; Rinaldi G; Carnevale-Schianca F; Maio M
    Cancer Invest; 2014 May; 32(4):144-9. PubMed ID: 24484235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term effects of BRAF inhibitors in melanoma treatment: friend or foe?
    Sloot S; Fedorenko IV; Smalley KS; Gibney GT
    Expert Opin Pharmacother; 2014 Apr; 15(5):589-92. PubMed ID: 24456413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [New treatment options for metastatic melanoma].
    Tietze JK; Berking C
    Dtsch Med Wochenschr; 2014 Jul; 139(28-29):1462-7. PubMed ID: 24983194
    [No Abstract]   [Full Text] [Related]  

  • 34. Selumetinib plus dacarbazine versus placebo plus dacarbazine as first-line treatment for BRAF-mutant metastatic melanoma: a phase 2 double-blind randomised study.
    Robert C; Dummer R; Gutzmer R; Lorigan P; Kim KB; Nyakas M; Arance A; Liszkay G; Schadendorf D; Cantarini M; Spencer S; Middleton MR
    Lancet Oncol; 2013 Jul; 14(8):733-40. PubMed ID: 23735514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of dabrafenib in the treatment of patients with BRAF V600-mutated metastatic melanoma in a Named Patient Program.
    Martin-Algarra S; Hinshelwood R; Mesnage S; Cebon J; Ferrucci PF; Aglietta M; Neyns B; Chiarion-Sileni V; Lindsay CR; Del Vecchio M; Linardou H; Merelli B; Tonini G; Atkinson V; Freivogel K; Stein D; Dalland L; Lau M; Legenne P; Queirolo P; Millward M
    Melanoma Res; 2019 Oct; 29(5):527-532. PubMed ID: 31095039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Good clinical and radiological response to BRAF inhibitor in patient with metastatic thin melanoma.
    Quintyne KI; Baker S; Wallis F; Gupta R
    BMJ Case Rep; 2012 Jun; 2012():. PubMed ID: 22744255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymph node metastases of melanoma: challenges for BRAF mutation detection.
    Chen G; Dudley J; Tseng LH; Smith K; Gurda GT; Gocke CD; Eshleman JR; Lin MT
    Hum Pathol; 2015 Jan; 46(1):113-9. PubMed ID: 25456393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overwhelming response to Dabrafenib in a patient with double BRAF mutation (V600E; V600M) metastatic malignant melanoma.
    Ponti G; Tomasi A; Pellacani G
    J Hematol Oncol; 2012 Oct; 5():60. PubMed ID: 23031422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BRAF inhibitor therapy-associated melanocytic lesions lack the BRAF V600E mutation and show increased levels of cyclin D1 expression.
    Mudaliar K; Tetzlaff MT; Duvic M; Ciurea A; Hymes S; Milton DR; Tsai KY; Prieto VG; Torres-Cabala CA; Curry JL
    Hum Pathol; 2016 Apr; 50():79-89. PubMed ID: 26997441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful desensitization protocol for hypersensitivity reaction probably caused by dabrafenib in a patient with metastatic melanoma.
    Bar-Sela G; Abu-Amna M; Hadad S; Haim N; Shahar E
    Jpn J Clin Oncol; 2015 Sep; 45(9):881-3. PubMed ID: 26056325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.